Mango Inc is exhibiting its rapid bioburden and sterility products at the PDA Micro Conference in Washington D.C. on 26 through 28 October.

At Mango, we believe sterility and bioburden testing shouldn’t take weeks. That’s why we built the Mango M6 — a rapid, growth-based microbiology platform that delivers clear results in hours, not days. Unlike traditional systems that rely on dyes, stains, and complex workflows, Mango is designed for simplicity, accuracy, and speed. Our platform gives QC teams the confidence to release products faster while maintaining the highest standards of compliance and patient safety. We partner with leading pharmaceutical manufacturers to help them: Accelerate manufacturing decisions with real-time sterility and bioburden insights, Simplify QC workflows with intuitive, growth-based technology and stay audit-ready with data integrity and 21 CFR Part 11 compliant software. Mango is more than a tool — it’s a technological leap in microbiology: faster, easier, and built for the future of advanced manufacturing.